According to IDEXX Laboratories's latest financial reports the company's total liabilities are A$2.70 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | A$2.73 B | 4.77% |
2023-12-31 | A$2.60 B | -17.06% |
2022-12-31 | A$3.14 B | 30.37% |
2021-12-31 | A$2.41 B | 11.52% |
2020-12-31 | A$2.16 B | -8.55% |
2019-12-31 | A$2.36 B | 7.65% |
2018-12-31 | A$2.19 B | -3.02% |
2017-12-31 | A$2.26 B | -0.44% |
2016-12-31 | A$2.27 B | 6.25% |
2015-12-31 | A$2.14 B | 38.27% |
2014-12-31 | A$1.54 B | 93.81% |
2013-12-31 | A$0.79 B | 77.57% |
2012-12-31 | A$0.44 B | -6.13% |
2011-12-31 | A$0.47 B | 50.73% |
2010-12-31 | A$0.31 B | -2.86% |
2009-12-31 | A$0.32 B | -29.45% |
2008-12-31 | A$0.46 B | 53.69% |
2007-12-31 | A$0.30 B | 58.92% |
2006-12-31 | A$0.18 B | 14.49% |
2005-12-31 | A$0.16 B | 10.48% |
2004-12-31 | A$0.15 B | 2.78% |
2003-12-31 | A$0.14 B | 7.65% |
2002-12-31 | A$0.13 B | -2.97% |
2001-12-31 | A$0.13 B |